{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-006269","form_type":"8-K/A","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.670740+00:00","generated_at":"2026-05-15T22:40:06.855524+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pulse Biosciences CCO Kevin P. Danahy resigns effective immediately","bullets":["Kevin P. Danahy, Chief Commercial Officer, resigned effective February 27, 2026.","No reason for the resignation was disclosed in the filing.","No replacement has been named at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-006269","json":"https://secwatch.observer/filing/0001437749-26-006269.json","markdown":"https://secwatch.observer/filing/0001437749-26-006269.md","text":"https://secwatch.observer/filing/0001437749-26-006269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/0001437749-26-006269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926006269/plse20260228d_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:40:06.855524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}